首页> 外文期刊>Knee surgery, sports traumatology, arthroscopy: official journal of the ESSKA >Cell-free collagen type I matrix for repair of cartilage defects-clinical and magnetic resonance imaging results
【24h】

Cell-free collagen type I matrix for repair of cartilage defects-clinical and magnetic resonance imaging results

机译:用于修复软骨缺损的无细胞I型胶原基质-临床和磁共振成像结果

获取原文
获取原文并翻译 | 示例
           

摘要

Purpose: Several well-described techniques are available for the treatment of chondral and osteochondral defects. The aim of the study was to assess the efficacy of a single-stage procedure incorporating a new cell-free collagen type I gel for the treatment of small chondral and osteochondral defects in the knee evaluated at 2-year follow-up. Methods: Fifteen patients were treated with a cell-free collagen type I gel matrix of 11 mm diameter. The grafts were implanted in the debrided cartilage defect and fixed by press-fit only. The clinical outcome was assessed preoperatively and at 6 weeks, and 6, 12 and 24 months after surgery using the International Knee Documentation Committee (IKDC) score, Tegner activity scale and visual analogue scale (VAS). Graft attachment rate was assessed 6 weeks postoperatively using magnetic resonance imaging (MRI). Cartilage regeneration was evaluated using the Magnetic Observation of Cartilage Repair Tissue (MOCART) score at 6, 12 and 24 months after implantation. Clinical results were correlated with MRI findings. Results: Six male and nine female patients were included in this study, with a mean age of 26 (range: 19-40). No complications were reported. The mean VAS values after 6 weeks and the mean IKDC patient values after 6 months were significantly improved from the preoperative values (P = 0. 005 and P = 0. 009, respectively). This improvement remained up to the latest follow-up. There were no significant differences between the median preoperative and postoperative Tegner values (n. s.). Significant improvement of the mean MOCART score was observed after 12 months and remained by 24 months (P < 0. 001). MR images showed that in 14 of the 15 patients, the graft was completely attached by 6 weeks postoperatively. At 24 months after implantation, MRI demonstrated complete filling in all cases with a mainly smooth surface, complete integration of the border zone, homogenous structure of the repaired tissue and nearly normal signal intensity. No correlation between any variables of the MOCART score and the clinical scores was observed. Conclusions: The present study reveals that the new method produces both good clinical and magnetic resonance imaging results. Use of press-fit only implanted grafts of a smaller diameter leads to a high attachment rate at 24-month follow-up. Level of evidence: IV.
机译:目的:几种众所周知的技术可用于治疗软骨和骨软骨缺损。这项研究的目的是评估合并了新型无细胞I型胶原蛋白凝胶的单阶段程序在2年随访中评估的治疗膝部小软骨和骨软骨缺损的功效。方法:15例患者接受了直径11 mm的无细胞I型胶原蛋白凝胶基质的治疗。将移植物植入清创的软骨缺损处,并仅通过压入配合固定。使用国际膝关节文献委员会(IKDC)评分,泰格纳活动量表和视觉模拟量表(VAS)对术前,术后6周,术后6周,6、12和24个月评估临床结局。术后6周使用磁共振成像(MRI)评估移植物的附着率。植入后第6、12和24个月使用软骨修复组织磁观察(MOCART)评分评估软骨的再生。临床结果与MRI检查结果相关。结果:本研究包括6例男性和9例女性患者,平均年龄26岁(范围:19-40)。没有并发症的报道。 6周后的VAS平均值和6个月后的IKDC患者平均值较术前有明显改善(分别为P = 0. 005和P = 0. 009)。这项改进一直持续到最新的随访。术前和术后Tegner值中位数之间无显着差异(n。s。)。在12个月后观察到平均MOCART评分有显着改善,并在24个月后保持不变(P <0. 001)。 MR图像显示,在15例患者中的14例中,术后6周移植物已完全附着。植入后24个月,MRI证实所有病例均完全充满,表面光滑,边界区完全融合,修复组织的结构均匀,信号强度接近正常。没有观察到任何MOCART得分变量与临床得分之间的相关性。结论:本研究揭示了该新方法产生了良好的临床和磁共振成像结果。仅压配合植入的较小直径的移植物在24个月的随访中会导致较高的附着率。证据级别:IV。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号